GSK anti-malaria drug not harmful for pregnant women: Study
In the study, published in the Archives of Internal Medicine, researchers looked at data on nearly 571,000 births in Denmark from 2000 to 2008, Reuters.com reported. On the
WuXi XDC Cayman has signed an agreement to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 payload-linker technology platform for the development of an antibody-drug conjugate (ADC) candidate.
Sativex is an endocannabinoid system modulator made up principally of two active ingredients -THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol). Sativex, administered as an oral spray, is specifically designed for
iBIO Institute orchestrates business leadership in the service of educational programs and job-creating technology startups. PROPEL helps to guide the development of formation-stage and early-stage life sciences companies